Mercer Global Advisors Inc. ADV Has $4.09 Million Stake in DocuSign, Inc. (NASDAQ:DOCU)

Mercer Global Advisors Inc. ADV increased its position in DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 91.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 46,439 shares of the company's stock after buying an additional 22,158 shares during the quarter. Mercer Global Advisors Inc. ADV's holdings in DocuSign were worth $4,087,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. FMR LLC boosted its position in shares of DocuSign by 178.2% during the 4th quarter. FMR LLC now owns 6,101,024 shares of the company's stock valued at $548,726,000 after purchasing an additional 3,908,139 shares in the last quarter. American Century Companies Inc. boosted its holdings in DocuSign by 18.5% during the fourth quarter. American Century Companies Inc. now owns 5,315,459 shares of the company's stock worth $478,072,000 after buying an additional 831,611 shares in the last quarter. Jericho Capital Asset Management L.P. lifted its position in shares of DocuSign by 34.0% during the 4th quarter. Jericho Capital Asset Management L.P. now owns 4,754,753 shares of the company's stock valued at $427,642,000 after acquiring an additional 1,205,500 shares during the last quarter. Renaissance Technologies LLC raised its position in shares of DocuSign by 4.9% during the fourth quarter. Renaissance Technologies LLC now owns 4,363,292 shares of the company's stock worth $392,434,000 after purchasing an additional 205,304 shares during the period. Finally, Geode Capital Management LLC boosted its position in shares of DocuSign by 7.2% in the 4th quarter. Geode Capital Management LLC now owns 3,732,363 shares of the company's stock valued at $335,147,000 after purchasing an additional 249,179 shares during the period. Institutional investors own 77.64% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have commented on DOCU shares. Hsbc Global Res raised shares of DocuSign from a "moderate sell" rating to a "hold" rating in a research note on Friday, April 11th. JPMorgan Chase & Co. upgraded DocuSign from an "underweight" rating to a "neutral" rating and increased their target price for the company from $70.00 to $75.00 in a report on Monday, March 10th. HSBC raised DocuSign from a "reduce" rating to a "hold" rating and set a $70.00 price target on the stock in a research report on Friday, April 11th. Morgan Stanley reduced their price target on shares of DocuSign from $97.00 to $92.00 and set an "equal weight" rating for the company in a research report on Wednesday, April 16th. Finally, Robert W. Baird set a $93.00 target price on shares of DocuSign in a research report on Friday, March 14th. One investment analyst has rated the stock with a sell rating, eleven have given a hold rating and four have assigned a buy rating to the company. According to MarketBeat, DocuSign presently has a consensus rating of "Hold" and a consensus price target of $92.46.

Insider Buying and Selling

In related news, Director Teresa Briggs sold 534 shares of DocuSign stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $87.41, for a total transaction of $46,676.94. Following the transaction, the director now owns 8,270 shares of the company's stock, valued at $722,880.70. This trade represents a 6.07 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Blake Jeffrey Grayson sold 16,111 shares of DocuSign stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $83.20, for a total transaction of $1,340,435.20. Following the transaction, the chief financial officer now directly owns 93,960 shares in the company, valued at approximately $7,817,472. This represents a 14.64 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 55,851 shares of company stock valued at $4,607,439 over the last ninety days. Insiders own 1.01% of the company's stock.

DocuSign Stock Performance

Shares of DOCU stock traded down $0.85 during mid-day trading on Friday, reaching $83.29. The company's stock had a trading volume of 860,718 shares, compared to its average volume of 2,745,218. The firm's 50-day moving average is $80.12 and its two-hundred day moving average is $84.30. The company has a market cap of $16.87 billion, a P/E ratio of 17.17, a PEG ratio of 6.94 and a beta of 1.21. DocuSign, Inc. has a 1-year low of $48.70 and a 1-year high of $107.86.

DocuSign (NASDAQ:DOCU - Get Free Report) last announced its quarterly earnings results on Thursday, March 13th. The company reported $0.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.84 by $0.02. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The firm had revenue of $776.25 million during the quarter, compared to the consensus estimate of $760.94 million. During the same period last year, the firm posted $0.76 EPS. The firm's quarterly revenue was up 9.0% on a year-over-year basis. Sell-side analysts anticipate that DocuSign, Inc. will post 1.17 EPS for the current year.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.